DR.WU Skincare Co., Ltd.(TW:6523)
NT$81.30+0.80 (+0.99%)
TW:6523
DR.WU Skincare Co., Ltd. financials statements
NT$81.30
At close:+0.80 (+0.99%)
DR.WU Skincare Co., Ltd. (6523) Ratios
DR.WU Skincare Co., Ltd. Ratios
TW:6523's free cash flow for Q2 2026 was NT$138.54M. For the 2026 fiscal year, TW:6523's free cash flow was decreased by NT$-710.00K and operating cash flow was NT$139.25M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.71 | 5.01 | 5.62 | 7.39 | 6.06 |
| Quick Ratio | 4.88 | 4.37 | 4.97 | 6.86 | 5.64 |
| Cash Ratio | 1.60 | 1.25 | 1.64 | 2.97 | 3.68 |
| Solvency Ratio | 1.53 | 1.64 | 1.49 | 1.38 | 1.04 |
| Operating Cash Flow Ratio | 1.67 | 1.73 | 1.36 | 1.49 | 1.04 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -5.39 |
| Net Current Asset Value | NT$ 931.27M | NT$ 974.03M | NT$ 1.33B | NT$ 1.37B | NT$ 1.39B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.00 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.03 | 0.03 | 0.00 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.03 | 0.03 | 0.00 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.17 | 1.20 | 1.20 | 1.17 | 1.19 |
| Debt Service Coverage Ratio | 259.94 | 579.37 | 1585.49 | 665.78 | -5.84 |
| Interest Coverage Ratio | 307.25 | 626.43 | 1788.23 | 807.11 | 486.77 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Interest Debt Per Share | 0.94 | 1.06 | 0.12 | 0.36 | 0.58 |
| Net Debt to EBITDA | -0.63 | -0.45 | -0.88 | -1.46 | -2.61 |
| Profitability Margins | |||||
| Gross Profit Margin | 68.96% | 70.71% | 71.58% | 71.00% | 62.78% |
| EBIT Margin | 37.91% | 48.01% | 46.26% | 45.82% | 33.71% |
| EBITDA Margin | 38.74% | 48.69% | 47.09% | 46.86% | 34.81% |
| Operating Profit Margin | 36.56% | 42.27% | 43.09% | 45.81% | 33.71% |
| Pretax Profit Margin | 37.79% | 47.94% | 46.24% | 45.76% | 33.64% |
| Net Profit Margin | 29.98% | 38.35% | 37.35% | 36.68% | 26.78% |
| Continuous Operations Profit Margin | 29.98% | 38.35% | 37.35% | 36.68% | 26.78% |
| Net Income Per EBT | 79.34% | 80.00% | 80.78% | 80.17% | 79.63% |
| EBT Per EBIT | 103.37% | 113.41% | 107.30% | 99.89% | 99.78% |
| Return on Assets (ROA) | 22.02% | 27.22% | 24.06% | 19.07% | 16.18% |
| Return on Equity (ROE) | 25.85% | 32.73% | 28.81% | 22.24% | 19.30% |
| Return on Capital Employed (ROCE) | 30.81% | 35.08% | 33.18% | 27.14% | 24.03% |
| Return on Invested Capital (ROIC) | 24.25% | 27.88% | 26.72% | 21.62% | 19.69% |
| Return on Tangible Assets | 22.03% | 27.23% | 24.07% | 19.07% | 16.18% |
| Earnings Yield | 6.57% | 7.05% | 6.20% | 7.29% | 6.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.63 | 6.99 | 8.02 | 7.00 | 7.32 |
| Payables Turnover | 12.17 | 14.04 | 5.15 | 5.75 | 4.58 |
| Inventory Turnover | 2.15 | 2.25 | 1.71 | 2.33 | 3.57 |
| Fixed Asset Turnover | 38.15 | 42.08 | 148.61 | 63.73 | 49.13 |
| Asset Turnover | 0.73 | 0.71 | 0.64 | 0.52 | 0.60 |
| Working Capital Turnover Ratio | 1.18 | 1.06 | 0.83 | 0.66 | 0.67 |
| Cash Conversion Cycle | 181.92 | 188.64 | 187.90 | 145.14 | 72.24 |
| Days of Sales Outstanding | 42.29 | 52.25 | 45.49 | 52.13 | 49.87 |
| Days of Inventory Outstanding | 169.62 | 162.38 | 213.23 | 156.45 | 102.13 |
| Days of Payables Outstanding | 29.99 | 25.99 | 70.82 | 63.43 | 79.75 |
| Operating Cycle | 211.91 | 214.63 | 258.71 | 208.57 | 152.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 7.57 | 9.70 | 8.71 | 7.23 | 6.43 |
| Free Cash Flow Per Share | 7.44 | 9.64 | 8.64 | 7.20 | 6.35 |
| Dividend Paid and CapEx Coverage Ratio | 0.75 | 0.88 | 0.86 | 1.20 | 0.48 |
| Capital Expenditure Coverage Ratio | 57.67 | 158.80 | 119.61 | 204.41 | 85.96 |
| Operating Cash Flow Coverage Ratio | 8.32 | 9.35 | 77.76 | 20.78 | 11.36 |
| Operating Cash Flow to Sales Ratio | 0.29 | 0.35 | 0.35 | 0.35 | 0.26 |
| Free Cash Flow Yield | 6.28% | 6.43% | 5.68% | 6.95% | 6.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.23 | 14.18 | 16.12 | 13.71 | 15.27 |
| Price-to-Sales (P/S) Ratio | 4.57 | 5.44 | 6.02 | 5.03 | 4.09 |
| Price-to-Book (P/B) Ratio | 3.94 | 4.64 | 4.64 | 3.05 | 2.95 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 15.93 | 15.55 | 17.59 | 14.38 | 15.82 |
| Price-to-Operating Cash Flow Ratio | 15.65 | 15.46 | 17.45 | 14.31 | 15.63 |
| Price-to-Earnings Growth (PEG) Ratio | -0.58 | 1.16 | 0.65 | 0.93 | -0.28 |
| Enterprise Value Multiple | 11.16 | 10.73 | 11.91 | 9.27 | 9.15 |
| Enterprise Value | 5.05B | 6.49B | 6.38B | 4.03B | 3.52B |
| EV to EBITDA | 11.16 | 10.73 | 11.91 | 9.27 | 9.15 |
| EV to Sales | 4.32 | 5.22 | 5.61 | 4.34 | 3.19 |
| EV to Free Cash Flow | 15.07 | 14.93 | 16.38 | 12.42 | 12.31 |
| EV to Operating Cash Flow | 14.81 | 14.84 | 16.25 | 12.36 | 12.17 |
| Tangible Book Value Per Share | 30.08 | 32.29 | 32.72 | 33.94 | 34.07 |
| Shareholders’ Equity Per Share | 30.09 | 32.30 | 32.73 | 33.94 | 34.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.20 | 0.19 | 0.20 | 0.20 |
| Revenue Per Share | 25.95 | 27.57 | 25.25 | 20.57 | 24.55 |
| Net Income Per Share | 7.78 | 10.57 | 9.43 | 7.55 | 6.58 |
| Tax Burden | 0.79 | 0.80 | 0.81 | 0.80 | 0.80 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.32 | 0.27 | 0.28 | 0.30 | 0.28 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.77 | 0.73 | 0.75 | 0.77 | 0.78 |
Currency in TWD
